NCT06886464View on ClinicalTrials.gov

Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin

PHASE2RecruitingINTERVENTIONAL
Enrollment

698

Participants

Timeline

Start Date

July 16, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions
Acute Kidney Injury
Interventions
DRUG

Cilastatin Sodium

Intravenous cilastatin reconstituted in normal saline solution

DRUG

Placebo-Saline

Identical looking normal saline solution

Trial Locations (2)

T2N 1N4

RECRUITING

University of Calgary, Calgary

T6G 2R3

NOT_YET_RECRUITING

University of Alberta, Edmonton

All Listed Sponsors
collaborator

Alberta Health services

OTHER

collaborator

University of Alberta

OTHER

lead

Matthew James

OTHER

NCT06886464 - Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin | Biotech Hunter | Biotech Hunter